Silverarc Capital Management, LLC Fulcrum Therapeutics, Inc. Transaction History

Silverarc Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$6.7 - $12.0 $2.67 Million - $4.78 Million	398,436 New	398,436 $3.76 Million
Q4 2021 Feb 14, 2022	SELL	$14.0 - $28.44 $2.6 Million - $5.28 Million	-185,691 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $1.35 Million - $5.75 Million	185,691 New	185,691 $5.24 Million
Q2 2021 Aug 16, 2021	SELL	$8.09 - $12.0 $981,333 - $1.46 Million	-121,302 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$10.94 - $15.32 $1.15 Million - $1.61 Million	105,093 Added 648.36%	121,302 $1.43 Million
Q4 2020 Feb 16, 2021	BUY	$7.84 - $13.4 $127,078 - $217,200	16,209 New	16,209 $190,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.